novo nordisk copycat - Search News

News

Novo Nordisk, copycat and Weight-Loss Drug

The Wall Street Journal on MSN · 3d

Novo Nordisk’s Wegovy Weight-Loss Drug Sales Surge Despite Copycat Issues

Second-quarter sales of the blockbuster drug soared 67% on year, despite millions of U.S. patients using generic unbranded versions of the drug.

Reuters on MSN · 4d

Wegovy maker Novo Nordisk warns on continued copycat-drug challenge as new CEO readied

Novo Nordisk cautioned on Wednesday that it expects continued competition this year from copycat versions of its Wegovy obesity drug, as it battled pressure from compounding pharmacies in the United States and rival Eli Lilly.

Devdiscourse · 3d

Novo Nordisk Faces Challenges as Copycat Competition Intensifies

Novo Nordisk experiences heightened competition from copycat versions of its Wegovy obesity drug, affecting its market share, particularly in the U.S. The company is taking legal action against compounding pharmacies and exploring direct-to-consumer sales to remain competitive amid declining stock and sales expectations.

24m

Novo Nordisk is in trouble: the reasons why Ozempic is losing millions of dollars in sales

Once the golden child of the weight-loss boom, the Danish drugmaker now faces a painful financial slimming of its own.

3d

Novo Nordisk, TSMC, Glencore: Stocks Around the World in Focus

The pharmaceutical company's quarterly sales of its blockbuster Wegovy drug surged by two-thirds, despite many Americans ...

11don MSN

Novo Nordisk shares fall 20% after company names new CEO and lowers its financial outlook

Novo Nordisk said it expects weaker sales growth of its popular weight-loss drug Wegovy due to competition from copycat drugs.

3d

Cash pay is 'going to constitute a major part of the Wegovy business': Novo Nordisk CFO

Novo Nordisk CFO Karsten Munk Knudsen tells Yahoo Finance the company understands the pressure it is under to deliver better ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results